The efficiency of targeting strategies is typically assessed through biodistribution studies, which track the distribution of nanoparticles within the body. Imaging techniques like MRI, PET, and fluorescence imaging can visualize and quantify nanoparticle localization and accumulation at the target site. Additionally, therapeutic efficacy and toxicity studies provide insights into the clinical relevance of the targeting strategy.
